Clinical Trial Update: Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update for Tongmai Jiangtang Capsule evaluating cardiovascular outcomes in high-risk metabolic syndrome patients; enrollment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Cerebrovascular Disease
• Chronic Kidney Disease
• Metabolic Syndrome

Drugs mentioned

• Tongmai Jiangtang Capsule

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Metabolic Syndrome, Cardiovascular Disease (CKD) | Phase 3 | Status: ENROLLING_BY_INVITATION